IsoRay (NYSE:ISR) said yesterday that it plans to defend itself from lawsuits filed against it related to a press release published on May 20. The Richland, Wash.-based company is facing putative class-action lawsuits from shareholders accusing the company of making false or misleading statements about a clinical trial of its Cesium 131 brachytherapy seeds designed to treat cancer. IsoRay […]
IsoRay
IsoRay faces lawsuits alleging fudged clinical data
IsoRay (NYSE:ISR) is facing putative class-action lawsuits from shareholders accusing the company of making false or misleading statements about a clinical trial of its Cesium 131 brachytherapy seeds designed to treat cancer. The lawsuits, from at least 3 different shareholders, claim that IsoRay made false statements about a clinical study of Cesium 131. The study was the 1st […]
Invendo Medical raised $28 million for its single-use colonoscopy system | Medtech funding stories for the week of Mar. 24, 2014
IsoRay drops hard on news of $14.7M direct offering
Wall Street give IsoRay Medical’s (AMEX:ISR) shares a beating today after the company announced that it had sold about $14.7 million in common stock to a pair of unnamed institutional investors.
Medtech personnel moves for the week of Mar. 17, 2014
IsoRay mourns death of vice-chair Robert Kauffman | Personnel Moves
Radiation therapy devices maker IsoRay (AMEX:ISR) announced the sudden death of company vice-chairman Robert Kauffman, who passed away on March 7.
Kauffman had been with the company since 2005 and was named vice-chairman in 2008. IsoRay is looking to fill the hole he left behind, but there are no immediate nominations or arrangements, according to an IsoRay regulatory filing.
Endo Health taps new CFO from Becton Dickinson | Personnel Moves
Rep. Paulsen expects device tax repeal on the House floor this week (video) | MassDevice.com On Call
MASSDEVICE ON CALL — Rep. Erik Paulsen’s long-running effort to repeal the medical device excise tax is nearing a climax in the House, the Congressman said during a recent episode of his regular "Correspondence Corner" videos.
Before answering questions sent by his constituents, Paulsen gave a shout out to Minnesota medical device makers and said he expects his tax repeal bill to get a House vote this week.
Nevro wins FDA approval to launch spinal stimulation trial | Regulatory Roundup
Masimo meets The Street, shares rise | Earnings Roundup
Masimo (NSDQ:MASI) met Wall Street’s forecast for its full-year and 4th-quarter earnings, giving its shares a 2% bump yesterday and sending them another 3% higher today.
The Irvine, Calif.-based patient monitoring systems maker reported profits of $$13.8 million, or 23 cents per share, on sales of $112.3 million for the 3 months ended Dec. 31, 2011, for a top-line increase of 6.4% but a bottom-line decline of 14.2%, compared with Q4 2010.
Supreme Court considers medical patents | Legal News
The U.S. Supreme Court heard oral arguments this week in a case that could have wide-reaching implications for health care: Whether medical patents should be allowed.
At issue is the specter of doctors being sued for patent infringement based on treatment decisions derived from the scientific research underpinning the patent.
